Business Description
Senti Biosciences Inc
NAICS : 325412
SIC : 2834
ISIN : US81726A1007
Description
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 2.17 | |||||
| Debt-to-EBITDA | -0.61 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 70.5 | |||||
| 3-Year EBITDA Growth Rate | -38.5 | |||||
| 3-Year EPS without NRI Growth Rate | -45.6 | |||||
| 3-Year FCF Growth Rate | -35.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.23 | |||||
| 9-Day RSI | 46.18 | |||||
| 14-Day RSI | 46.05 | |||||
| 6-1 Month Momentum % | -36.78 | |||||
| 12-1 Month Momentum % | -37.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.92 | |||||
| Quick Ratio | 1.92 | |||||
| Cash Ratio | 1.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 15.01 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -1766.89 | |||||
| ROE % | -133.22 | |||||
| ROA % | -71.17 | |||||
| ROIC % | -87.62 | |||||
| ROC (Joel Greenblatt) % | -132.02 | |||||
| ROCE % | -70.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.8 | |||||
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.61 | |||||
| EV-to-EBIT | -0.54 | |||||
| EV-to-EBITDA | -0.6 | |||||
| EV-to-Revenue | 17.21 | |||||
| EV-to-FCF | -0.97 | |||||
| Earnings Yield (Greenblatt) % | -185.19 | |||||
| FCF Yield % | -355.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SNTI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Senti Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.978 | ||
| EPS (TTM) ($) | -15.54 | ||
| Beta | 0 | ||
| Volatility % | 93.4 | ||
| 14-Day RSI | 46.05 | ||
| 14-Day ATR ($) | 0.164161 | ||
| 20-Day SMA ($) | 2.18653 | ||
| 12-1 Month Momentum % | -37.5 | ||
| 52-Week Range ($) | 1.5201 - 7.43 | ||
| Shares Outstanding (Mil) | 4.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Senti Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Senti Biosciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Senti Biosciences Inc Frequently Asked Questions
What is Senti Biosciences Inc(SNTI)'s stock price today?
The current price of SNTI is $2.14. The 52 week high of SNTI is $7.43 and 52 week low is $1.52.
When is next earnings date of Senti Biosciences Inc(SNTI)?
The next earnings date of Senti Biosciences Inc(SNTI) is 2025-03-21 Est..
Does Senti Biosciences Inc(SNTI) pay dividends? If so, how much?
Senti Biosciences Inc(SNTI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers